Sanofi Accused Of Blocking Rival On Diabetes Drug
Pharmaceutical giant Sanofi unlawfully claimed it had additional patents covering one of its diabetes drugs in a bid to stave off new competition, according to a proposed class action a Puerto...To view the full article, register now.
Already a subscriber? Click here to view full article